ABSTRACT. Serum alpha-fetoprotein (AFP) values were measured in hepatic diseased dogs with or without tumor and non-hepatic tumor bearing dogs by a sandwich ELISA using anti-dog AFP antiserum. Serum AFP values were less than 70 ng/ml in clinically healthy dogs. The values in dogs with hepatocellular carcinoma were higher than 1,400 ng/ml in 7 of 9 dogs, wherever those in two dogs with cholangiocarcinoma were in the normal range. Serum AFP values in hepatic diseased dogs without tumor were also high, however, the values were below 500 ng/ml in 90% of the dogs. In non-hepatic tumor dogs, serum AFP values were less than 500 ng/ml in 76% of the dogs. In the surgically removal cases with hepatocellular carcinoma, serum AFP values rapidly decreased. These results suggested that the sandwich ELISA using anti-dog AFP antiserum was an available method for diagnosis of hepatocellular carcinoma in dogs.-KEY WORDS: alpha-fetoprotein, canine, ELISA, tumor.J. Vet. Med. Sci. 61(6): 657-659, 1999 with hepatocellular carcinoma were also monitored AFP values after surgical removal of masses. Serum: Sera were collected by the usual methods, and kept below 20°C until assay.Preparation of AFP and antibodies: Canine AFP and antidog AFP antiserum were prepared according to the previously described method [17].ELISA for canine AFP: The protein concentration of purified AFP was measured by the Coomassie protein assay methods (Pierce, U.S.A.) using bovine serum albumin (BSA) as a standard. The ELISA for canine AFP was developed by the previously reported avidin-biotin sandwich method with minor modifications [17]. Briefly, the immunoglobulin G (IgG) fraction of anti-dog AFP antiserum from rabbits was coated on 96-well microplates (flat-bottom) at 5 µg per well. The wells were blocked with PBS containing 0.5% BSA, and washed with PBS containing 0.05% Tween 20 (TPBS) by an ELISA plate washer (Immunowash; BioRad, USA). Serum samples were diluted with TPBS at 1:2, 1:10, and 1:50. A standard solution of canine AFP was also diluted at concentrations of 0.25 ng/ml to 600 ng/ml in TPBS. The IgG fraction of anti-dog AFP antiserum was labeled with N-hydroxysuccimidobiotins (Sigma, U.S.A.) as shown by Coligan et al. [3]. The peroxidase-conjugated streptavidin was purchased from Dako (Denmark) and the chromogen 2',2' azino-bis (3-ethylbenzthiazolin-6-sulfonic acid) from Sigma (U.S.A.). Absorption of the samples and standards were measured at 405 nm. Serum AFP was measured in less than 3 weeks after storage, because storage time would affect AFP values [7]. RESULTS Serum AFP values:Serum AFP values in clinically healthy dogs were less than 70 ng/ml. Serum AFP values Serum alpha-fetoprotein (AFP) values have been used for the diagnosis of hepatocellular carcinoma [4,[5][6]14] and also for the understanding pathophysiological states in hepatic failure [8][9] in man. The values in dogs measured by enzyme-linked immunosorbent assay (ELISA) or radio immuno-assay (RIA) using anti-human AFP antibody were also reported [7,9,15], as the incidence of hepato...
ABSTRACT. Group A consisted of chickens infected with a single dose of Ascaris suum and group B of chickens infected with two successive doses. At days 1, 3, 7, 14 and 21 after the first or second infection dose, six chickens from each group were sacrificed. In both groups, larvae were recovered from the livers on days 1, 3, and 7 and lungs on days 3 and 7. No larvae were detected in chickens on day 14. Clear white lesions were noticed only on the livers from chickens of group B at day 7 but had disappeared at day 14. A comparison with group B showed mild histological changes that developed relative to the livers from group A. KEY WORDS: Ascaris suum, chickens, visceral larval migrans.J. Vet. Med. Sci. 70(10): 1129-1131, 2008 Similar to the visceral larval migrans (VLM) of Toxocara canis (T. canis) infection [3], Ascaris suum (A. suum) infection in humans has been reported in Japan [2,8,10,11,15]. It was considered that at least three human cases were caused by eating fresh raw meat and liver from cattle or chickens [2,8,10]. These reports suggest that chickens may play an important role in the zoonotic transmission of A. suum. To clarify the VLM of A. suum larvae in infected chickens, an investigation was carried out on the distribution of larvae and the pathological changes in the livers.Fresh A. suum eggs were obtained from female worms at a local abattoir. Embryonation of the eggs was performed as described by Tsuji et al. [16]. A total number of 65 male broiler chickens aged about 20-days old were used. Initially, groups A (chickens infected with a single dose of A. suum) and B (chicken infected two successive dose) of 30 chickens each received 10,000 eggs and were kept in cages. The same number of eggs were given again to chickens of group B 17 days after the first dose. On days 1, 3, 7, 14, and 21 after the first or second infection, six chickens from each group were sacrificed by cervical dislocation. Larvae were collected from the liver (lobus dexter), lung, pectoral muscle (musculus pectoralis profurdus; about 30 g), and the duodenum (without contents and mucus) using the Baerman method. The contents and mucus of the duodenum were fixed separately in 5% formalin solution and examined microscopically. A video micrometer was used for the measurement of the length of larvae. Statisitical analysis of differences in larval counts between both groups on the same day after first or second infection was done using Statisitica (Stat Soft, Tulsa, OK, U.S.A., P<0.05). The liver (lobus sinister) was investigated macroscopically and fixed in 10% buffered formalin solution. Paraffin sections were stained with hematoxylin and eosin (HE) or with Azan. To examine the lesion in repeatedly infected animals, remaining 5 chickens (group C) were infected with 10,000 eggs twice weekly for five weeks and sacrificed 7 days after the final infection.No clinical signs were observed in any of the infected chickens during the study period. Table 1 shows the distribution of A. suum larvae in chickens of groups A and B. Larvae were ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.